Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
D3A Medical Systems is a French medical technology company specializing in advanced 3D medical imaging software for cardiovascular and neurovascular applications. The company's core technology, the D3A (Digital 3D Anatomy) platform, provides clinicians with high-precision 3D reconstructions from standard 2D medical images to assist in diagnosis, surgical planning, and the selection of medical devices. Their solutions are designed to improve the accuracy of interventions such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR). By leveraging proprietary algorithms, D3A Medical Systems aims to reduce procedural risks and optimize patient outcomes in complex vascular procedures. The company's software is CE-marked and utilized by interventional cardiologists and vascular surgeons to enhance procedural predictability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on D3A Medical Systems.